ArticleJournal of intensive medicine2026
Clinical models for predicting 30-day mortality in ARDS: A focus on ventilatory ratio-defined subgroups.
Article in Journal of intensive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: It is supposed that acute respiratory distress syndrome (ARDS) patients with increased dead space, indicated by elevated ventilatory ratio (VR), had higher mortality. The difference in mortality predictors among ARDS patients categorized by VR remains unclear, so we aimed to investigate the risk factors for mortality prediction in subgroups defined by VR and develop risk models to predict the 30-day mortality in distinct ARDS subgroups. Methods: This study performed a retrospective analysis using the Medical Information Mart for Intensive Care IV (MIMIC-IV) and eICU Collaborative Research Database (eICU-CRD) databases, as well as data from NHLBI ARDS Clinical Trials Network (ARDSnet). Patients were divided into high VR (VR ≥2) and low VR (VR <2) subgroups based on baseline VR. In ARDSnet cohort, two 30-day mortality risk prediction models were constructed using logistic regression, internally validated using the bootstrap method, and externally validated in the MIMIC-IV and eICU-CRD cohorts. The performance of models was evaluated using receiver operating characteristic curves, Brier scores, calibration curves, and decision curve analysis (DCA) curves, and DeLong test was used to compare the predictive efficacy of different models in each subgroup. Results: This study included a total of 2977 ARDS patients: 1031 in the high VR training cohort, 1506 in the low VR training cohort, 159 in the high VR external validation cohort, and 281 in the low VR external validation cohort. Through stepwise regression analysis, 11 predictors were finally selected to construct high VR prediction model including age, body mass index (BMI), heart rate, mean arterial pressure, body temperature, blood urea nitrogen (BUN), bilirubin, minute ventilation, peak inspiratory pressure, inspired oxygen fraction (FiO Conclusion: This study developed and validated prognostic prediction models for patients of high and low VR subgroups, respectively. The models demonstrated good discrimination, calibration, and clinical utility. Prognostic risk factors differed between high and low VR subgroups, and prediction models developed for specific VR subgroups exhibited better predictive performance within their respective subgroup populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.